Journal
JOURNAL OF CLINICAL MEDICINE
Volume 12, Issue 14, Pages -Publisher
MDPI
DOI: 10.3390/jcm12144776
Keywords
chronic myeloid leukemia; pediatric CML; priapism; leukostasis; hyperleukocytosis; leukapheresis; exchange transfusion; pediatric CML registry; penile puncture
Categories
Ask authors/readers for more resources
Pediatric chronic myeloid leukemia (CML) is a rare malignancy with priapism observed in approximately 3.2% of boys with pediatric CML. Priapism duration varied from hours to months, with intermittent priapism being the most common presentation. All patients exhibited splenomegaly and massive leukocytosis. Interventions for priapism included intravenous fluids, heparin, penile puncture, sympathomimetics, and surgical shunt operations. Long-term survivors responded well to treatment and maintained full erectile function.
Pediatric chronic myeloid leukemia (CML) is a very rare malignancy (age-related incidence 0.1/100,000) typically presenting with leucocyte counts >100,000/& mu;L. However, clinical signs of leukostasis are observed at diagnosis in only approximately 10% of all cases and among these, priapism is infrequent. Here, we analyze data from pediatric CML registries on the occurrence of priapism heralding diagnosis of CML in 16/491 (3.2%) boys (median age 13.5 years, range 4-18) with pediatric CML. In the cohort investigated, duration of priapism resulting in a diagnosis of CML was not reported in 5 patients, and in the remaining 11 patients, occurred as stuttering priapism over 3 months (n = 1), over 6 weeks (n = 1), over 1-2 weeks (n = 2), over several days (n = 2), or 24 h (n = 1), while the remaining 4 boys reported continuous erection lasting over 11-12 h. All patients exhibited splenomegaly and massive leukocytosis (median WBC 470,000/& mu;L, range 236,700-899,000). Interventions to treat priapism were unknown in 5 patients, and in the remaining cohort, comprised intravenous fluids & PLUSMN; heparin (n = 2), penile puncture (n = 5) & PLUSMN; injection of sympathomimetics (n = 4) & PLUSMN; intracavernous shunt operation (n = 1) paralleled by leukocyte-reductive measures. Management without penile puncture by leukapheresis or exchange transfusion was performed in 3 boys. In total, 7 out 15 (47%) long-term survivors (median age 20 years, range 19-25) responded to a questionnaire. All had maintained full erectile function; however, 5/7 had presented with stuttering priapism while in the remaining 2 patients priapism had lasted <12 h until intervention. At its extreme, low-flow priapism lasting for longer than 24 h may result in partial or total impotence by erectile dysfunction. This physical disability can exert a large psychological impact on patients' lives. In a narrative review fashion, we analyzed the literature on priapism in boys with CML which is by categorization stuttering or persisting as mostly painful, ischemic (low-flow) priapism. Details on the pathophysiology are discussed on the background of the different blood rheology of hyperleukocytosis in acute and chronic leukemias. In addition to the data collected, instructive case vignettes demonstrate the diagnostic and treatment approaches and the outcome of boys presenting with priapism. An algorithm for management of priapism in a stepwise fashion is presented. All approaches must be performed in parallel with cytoreductive treatment of leukostasis in CML which comprises leukapheresis and exchange transfusions & PLUSMN; cytotoxic chemotherapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available